GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rezolute Inc (NAS:RZLT) » Definitions » E10

Rezolute (Rezolute) E10 : $-25.71 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Rezolute E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Rezolute's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.270. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-25.71 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-04-29), Rezolute's current stock price is $2.66. Rezolute's E10 for the quarter that ended in Dec. 2023 was $-25.71. Rezolute's Shiller PE Ratio of today is .


Rezolute E10 Historical Data

The historical data trend for Rezolute's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rezolute E10 Chart

Rezolute Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -31.41 -34.10 -28.06

Rezolute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.66 -28.64 -28.06 -27.55 -25.71

Competitive Comparison of Rezolute's E10

For the Biotechnology subindustry, Rezolute's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rezolute's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rezolute's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Rezolute's Shiller PE Ratio falls into.



Rezolute E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rezolute's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.27/129.4194*129.4194
=-0.270

Current CPI (Dec. 2023) = 129.4194.

Rezolute Quarterly Data

per share eps CPI Adj_EPS
201403 -38.000 99.695 -49.330
201406 -5.542 100.560 -7.133
201409 -6.000 100.428 -7.732
201412 -8.000 99.070 -10.451
201503 -7.000 99.621 -9.094
201506 -6.000 100.684 -7.712
201509 -7.000 100.392 -9.024
201512 -8.500 99.792 -11.024
201603 -7.500 100.470 -9.661
201606 -19.000 101.688 -24.181
201609 -5.500 101.861 -6.988
201612 -6.000 101.863 -7.623
201703 -10.500 102.862 -13.211
201706 -6.500 103.349 -8.140
201709 -6.500 104.136 -8.078
201712 -5.500 104.011 -6.844
201803 -4.500 105.290 -5.531
201806 -11.000 106.317 -13.390
201809 -2.500 106.507 -3.038
201812 -3.500 105.998 -4.273
201903 -18.000 107.251 -21.721
201906 -0.748 108.070 -0.896
201909 -0.940 108.329 -1.123
201912 -1.140 108.420 -1.361
202003 -0.860 108.902 -1.022
202006 -0.610 108.767 -0.726
202009 -0.620 109.815 -0.731
202012 -0.880 109.897 -1.036
202103 -0.440 111.754 -0.510
202106 -0.780 114.631 -0.881
202109 -0.920 115.734 -1.029
202112 -0.800 117.630 -0.880
202203 -0.650 121.301 -0.694
202206 -0.402 125.017 -0.416
202209 -0.190 125.227 -0.196
202212 -0.260 125.222 -0.269
202303 -0.300 127.348 -0.305
202306 -0.250 128.729 -0.251
202309 -0.280 129.860 -0.279
202312 -0.270 129.419 -0.270

Add all the adjusted EPS together and divide 10 will get our e10.


Rezolute  (NAS:RZLT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Rezolute E10 Related Terms

Thank you for viewing the detailed overview of Rezolute's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Rezolute (Rezolute) Business Description

Traded in Other Exchanges
N/A
Address
275 Shoreline Drive, Suite 500, Redwood City, CA, USA, 94065
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
Executives
Brian Kenneth Roberts officer: Chief Medical Officer C/O REZOLUTE, INC., 201 REDWOOD SHORES PARKWAY, SUITE 315, REDWOOD CITY CA 94065
Gil M Labrucherie director 150 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Wladimir Hogenhuis director 60 LEVERONI COURT, NOVATO CA 94949
Nerissa Kreher director C/O AVROBIO, INC., ONE KENDALL SQ., BLDG. 300, STE. 201, CAMBRIDGE MA 02139
Handok, Inc. 10 percent owner 132, TEHERAN-RO, GANGNAM GU, SOUL M5 06235
Philippe Fauchet director C/O REZOLUTE, INC., 201 REDWOOD SHORES PARKWAY, SUITE 315, REDWOOD CITY CA 94065
Junghee Lim director C/O REZOLUTE, INC., 201 REDWOOD SHORE'S PARKWAY, SUITE 315, REDWOOD CITY CA 94065
Genexine Inc. 10 percent owner 700 DAEWANGPANGYO-RO, KOREA PARKBLDG. B, BUNDANG-GU, SEONGNAM-SI, GYEONGGI-DO M5 13488
Seline E. Miller officer: VP Finance & CAO C/O REZOLUTE, INC., 1450 INFINITE DRIVE, LOUISVILLE CO 80027
Young-jin Kim director 49, BONGEUNSA-RO 49-GIL, GANGNAM-GU, SEOUL M5 06100
Young Chul Sung director 101DONG 404HO, PARKTOWER APT. 69, SEOBINGGO-RO, YONGSAN-GU, SEOUL M5 04385
Keith A. Vendola officer: Chief Financial Officer 111 LIVORNO WAY, REDWOOD CITY CA 94065
Xoma Corp 10 percent owner 2200 POWELL STREET, SUITE 310, EMERYVILLE CA 94608
David F Welch director C/O INFINERA CORPORATION, 140 CASPIAN COURT, SUNNYVALE CA 94089
Morgan Fields officer: Chief Accounting Officer 890 SANTA CRUZ AVE., MENLO PARK CA 94025